{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:26:37Z","timestamp":1793060797282,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100024157","name":"Neurelis, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100024157","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40120-023-00568-4","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T11:01:56Z","timestamp":1704366116000},"page":"221-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rapid Rescue Treatment with Diazepam Nasal Spray Leads to Faster Seizure Cluster Termination in Epilepsy: An Exploratory Post Hoc Cohort Analysis"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7624-8825","authenticated-orcid":false,"given":"Sunita N.","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9373-0579","authenticated-orcid":false,"given":"Randa","family":"Jarrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-1642","authenticated-orcid":false,"given":"John M.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-8055","authenticated-orcid":false,"given":"Danielle A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8788-0722","authenticated-orcid":false,"given":"Enrique","family":"Carrazana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1299-0606","authenticated-orcid":false,"given":"Adrian L.","family":"Rabinowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"issue":"Pt 4","key":"568_CR1","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/brain\/aww019","volume":"139","author":"PJ Karoly","year":"2016","unstructured":"Karoly PJ, Freestone DR, Boston R, et al. Interictal spikes and epileptic seizures: their relationship and underlying rhythmicity. Brain. 2016;139(Pt 4):1066\u201378.","journal-title":"Brain"},{"key":"568_CR2","doi-asserted-by":"publisher","unstructured":"Jiruska P, Freestone D, Gnatkovsky V, Wang Y. An update on the seizures beget seizures theory. Epilepsia. 2023. https:\/\/doi.org\/10.1111\/epi.17721.","DOI":"10.1111\/epi.17721"},{"issue":"2","key":"568_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/WCO.0000000000000177","volume":"28","author":"SR Haut","year":"2015","unstructured":"Haut SR. Seizure clusters: characteristics and treatment. Curr Opin Neurol. 2015;28(2):143\u201350.","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"568_CR4","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/j.1528-1157.1999.tb01607.x","volume":"40","author":"SR Haut","year":"1999","unstructured":"Haut SR, Shinnar S, Moshe SL, O\u2019Dell C, Legatt AD. The association between seizure clustering and convulsive status epilepticus in patients with intractable complex partial seizures. Epilepsia. 1999;40(12):1832\u20134.","journal-title":"Epilepsia"},{"key":"568_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107836","volume":"117","author":"J Buchhalter","year":"2021","unstructured":"Buchhalter J, Shafer PO, Buelow JM, et al. Preferred practices for rescue treatment of seizure clusters: a consensus-driven, multi-stakeholder approach. Epilepsy Behav. 2021;117: 107836.","journal-title":"Epilepsy Behav"},{"key":"568_CR6","doi-asserted-by":"crossref","unstructured":"Haut SR, Nabbout R. Recognizing seizure clusters in the community: the path to uniformity and individualization in nomenclature and definition. Epilepsia. 2022;63 (Suppl 1):S6-S13","DOI":"10.1111\/epi.17346"},{"key":"568_CR7","doi-asserted-by":"crossref","unstructured":"Cereghino JJ, Mitchell WG, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E. Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The North American Diastat Study Group. Neurology. 1998;51(5):1274\u201382.","DOI":"10.1212\/WNL.51.5.1274"},{"issue":"26","key":"568_CR8","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1056\/NEJM199806253382602","volume":"338","author":"FE Dreifuss","year":"1998","unstructured":"Dreifuss FE, Rosman NP, Cloyd JC, et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med. 1998;338(26):1869\u201375.","journal-title":"N Engl J Med"},{"key":"568_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yebeh.2015.04.022","volume":"47","author":"RS Fisher","year":"2015","unstructured":"Fisher RS, Bartfeld E, Cramer JA. Use of an online epilepsy diary to characterize repetitive seizures. Epilepsy Behav. 2015;47:66\u201371.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"568_CR10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/epi.17237","volume":"63","author":"EC Wirrell","year":"2022","unstructured":"Wirrell EC, Nabbout R, Scheffer IE, et al. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1333\u201348.","journal-title":"Epilepsia"},{"issue":"5","key":"568_CR11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s40120-023-00515-3","volume":"12","author":"DA Becker","year":"2023","unstructured":"Becker DA, Wheless JW, Sirven J, Tatum WO, Rabinowicz AL, Carrazana E. Treatment of seizure clusters in epilepsy: a narrative review on rescue therapies. Neurol Ther. 2023;12(5):1439\u201355.","journal-title":"Neurol Ther"},{"key":"568_CR12","unstructured":"Electronic Medicines Compendium. Buccolam 2.5 mg oromucosal solution.  https:\/\/www.medicines.org.uk\/emc\/product\/2768\/smpc. Accessed 7 Sept 2021."},{"key":"568_CR13","unstructured":"Neuraxpharm. Neuraxpharm launches first product in Japan. Neuraxpharm. https:\/\/www.neuraxpharm.com\/se\/wp-content\/uploads\/sites\/29\/2021\/04\/en-neuraxpharm-launches-first-product-in-japan.pdf. Accessed 14 Apr 2023."},{"key":"568_CR14","doi-asserted-by":"crossref","unstructured":"Gidal B, Welty T, Cokley J, et al. Opportunities for community pharmacists to counsel patients with epilepsy and seizure clusters to overcome barriers and foster appropriate treatment. J Pharm Pract. 2022:8971900221126570","DOI":"10.1177\/08971900221126570"},{"key":"568_CR15","unstructured":"US Food and Drug Administration. Orphan Drug Act\u2014relevant excerpts. https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/orphan-drug-act-relevant-excerpts. Accessed 23 Sept 2021."},{"key":"568_CR16","unstructured":"Centers for Disease Control and Prevention. Epilepsy data and statistics. https:\/\/www.cdc.gov\/epilepsy\/data\/index.html. Accessed 22 Apr 2019."},{"issue":"11","key":"568_CR17","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1528-1157.1999.tb02047.x","volume":"40","author":"WG Mitchell","year":"1999","unstructured":"Mitchell WG, Conry JA, Crumrine PK, et al. An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance. North Am Diastat Group. Epilepsia. 1999;40(11):1610\u20137.","journal-title":"Epilepsia"},{"key":"568_CR18","unstructured":"UCB, Inc. Nayzilam\u00ae (midazolam nasal spray). Full prescribing information. Brussels: UCB, Inc.; 2023. https:\/\/www.ucb-usa.com\/nayzilam-prescribing-information.pdf. Accessed 13 Mar 2023."},{"key":"568_CR19","unstructured":"Neurelis, Inc. VALTOCO\u00ae (diazepam nasal spray). Full prescribing information. San Diego: Neurelis, Inc.; 2023. https:\/\/www.valtoco.com\/sites\/default\/files\/pdf\/Prescribing_Information.pdf. Accessed 13 Mar 2023."},{"issue":"4","key":"568_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/epi.16847","volume":"62","author":"J Cloyd","year":"2021","unstructured":"Cloyd J, Haut S, Carrazana E, Rabinowicz AL. Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters. Epilepsia. 2021;62(4):846\u201356.","journal-title":"Epilepsia"},{"issue":"1","key":"568_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48\u201361.","journal-title":"Epilepsy Curr"},{"key":"568_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","volume":"68","author":"M Gainza-Lein","year":"2019","unstructured":"Gainza-Lein M, Fernandez IS, Ulate-Campos A, Loddenkemper T, Ostendorf AP. Timing in the treatment of status epilepticus: from basics to the clinic. Seizure. 2019;68:22\u201330.","journal-title":"Seizure"},{"key":"568_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2020.12.014","volume":"86","author":"S Maier","year":"2021","unstructured":"Maier S, Godau J, Bosel J, Rosche J. Recognition and treatment of status epilepticus in the prehospital setting. Seizure. 2021;86:1\u20135.","journal-title":"Seizure"},{"key":"568_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jns.2016.10.004","volume":"370","author":"JY Cheng","year":"2016","unstructured":"Cheng JY. Latency to treatment of status epilepticus is associated with mortality and functional status. J Neurol Sci. 2016;370:290\u20135.","journal-title":"J Neurol Sci"},{"issue":"4","key":"568_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","volume":"75","author":"M Gainza-Lein","year":"2018","unstructured":"Gainza-Lein M, Sanchez Fernandez I, Jackson M, et al. Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus. JAMA Neurol. 2018;75(4):410\u20138.","journal-title":"JAMA Neurol"},{"issue":"3","key":"568_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ane.13363","volume":"143","author":"A Gutierrez-Viedma","year":"2021","unstructured":"Gutierrez-Viedma A, Parejo-Carbonell B, Romeral-Jimenez M, et al. Therapy delay in status epilepticus extends its duration and worsens its prognosis. Acta Neurol Scand. 2021;143(3):281\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"568_CR27","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/epi.17041","volume":"62","author":"JW Wheless","year":"2021","unstructured":"Wheless JW, Miller I, Hogan RE, et al. Final results from a phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy. Epilepsia. 2021;62(10):2485\u201395.","journal-title":"Epilepsia"},{"issue":"10","key":"568_CR28","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/epi.17385","volume":"63","author":"SN Misra","year":"2022","unstructured":"Misra SN, Sperling MR, Rao VR, et al. Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters. Epilepsia. 2022;63(10):2684\u201393.","journal-title":"Epilepsia"},{"issue":"2","key":"568_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/epi.17492","volume":"64","author":"P Meritam Larsen","year":"2023","unstructured":"Meritam Larsen P, Wustenhagen S, Terney D, Gardella E, Aurlien H, Beniczky S. Duration of epileptic seizure types: a data-driven approach. Epilepsia. 2023;64(2):469\u201378.","journal-title":"Epilepsia"},{"issue":"7624","key":"568_CR30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ"},{"issue":"Pt A","key":"568_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108013","volume":"121","author":"P Penovich","year":"2021","unstructured":"Penovich P, Wheless JW, Hogan RE, et al. Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: results from an exit survey of a phase 3, open-label, repeat-dose safety study. Epilepsy Behav. 2021;121(Pt A): 108013.","journal-title":"Epilepsy Behav"},{"key":"568_CR32","unstructured":"Bausch Health US, LLC. Diastat\u00ae C-IV (diazepam rectal gel). Full prescribing information. Bridgewater: Bausch Health US, LLC; 2023. http:\/\/www.diastat.com\/. Accessed 13 Mar 2023."},{"issue":"7","key":"568_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41582-022-00664-3","volume":"18","author":"RJ Burman","year":"2022","unstructured":"Burman RJ, Rosch RE, Wilmshurst JM, et al. Why won\u2019t it stop? The dynamics of benzodiazepine resistance in status epilepticus. Nat Rev Neurol. 2022;18(7):428\u201341.","journal-title":"Nat Rev Neurol"},{"key":"568_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107983","volume":"120","author":"GD Cascino","year":"2021","unstructured":"Cascino GD, Tarquinio D, Wheless JW, et al. Lack of observed tolerance to diazepam nasal spray (Valtoco\u00ae) after long-term rescue therapy in patients with epilepsy: interim results from a phase 3, open-label, repeat-dose safety study. Epilepsy Behav. 2021;120: 107983.","journal-title":"Epilepsy Behav"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-023-00568-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T14:12:58Z","timestamp":1705155178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-023-00568-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s40120-023-00568-4","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"At the time of this study, Sunita N Misra was an employee of and had received stock options from Neurelis, Inc. Randa Jarrar is an advisor for Neurelis, Inc. John N Stern is a consultant for Eisai, Jazz, Neurelis, Inc., SK Life Science, and UCB. Danielle A Becker is a consultant\/speaker for Neurelis, Inc., SK Life Science, UCB, and Jazz Pharmaceuticals. Enrique Carrazana is an employee of and has received stock and stock options from Neurelis, Inc.\u00a0Adrian L Rabinowicz is an employee of and has received stock options from Neurelis, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The ethics committees or institutional review boards of the study centers approved study procedures. The study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. All patients or parents\/guardians provided written informed consent prior to participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}